Shibani Nicum

5PUBLICATIONS
46CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 09, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.

Karim H El-Shakankery, Joanna Kefas, Kieran Palmer

|Sep 08, 2024
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.

Luke Steventon, Kenneth K C Man, Shibani Nicum

|Jul 20, 2024
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Alexander B Olawaiye, Jae-Weon Kim, Andrea Bagameri

|Jan 20, 2024
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.

Shibani Nicum, Naomi McGregor, Rachel Austin

|Apr 18, 2023
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.

Robert D Morgan, Andrew R Clamp, Bethany M Barnes

Pageof 1

Frequent Collaborators

2 joint publications

Rebecca S Kristeleit

2 joint publications

Susana Banerjee

2 joint publications

Iain McNeish

2 joint publications

Jonathan A Ledermann